Free shipping on orders of €99 or more

SR-9011 5mg/capsule, 60 caps

SR-9011 5mg/capsule, 60 caps

Original price was: €99,95.Current price is: €74,96.
€74,96
Add to cart €74,96
Accepted payment methods
Free shipping on orders of €99 or more. USPS Regular Shipping: €11,95 · FedEx 2 Days Delivery: €28,99 · FedEx Overnight Delivery: €40,99 Shipping details

SR-9011 is a synthetic small-molecule agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2), members of the nuclear receptor superfamily that function as ligand-dependent transcriptional repressors.

Original price was: €99,95.Current price is: €74,96.
€74,96
Add to cart €74,96
Accepted payment methods
Free shipping on orders of €99 or more. USPS Regular Shipping: €11,95 · FedEx 2 Days Delivery: €28,99 · FedEx Overnight Delivery: €40,99 Shipping details

-25% on everything – until October 31
25% off regular prices, replacing other product sales. Only the crypto payment discount can be combined.

Overview

SR-9011 is a synthetic small-molecule agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2), members of the nuclear receptor superfamily that function as ligand-dependent transcriptional repressors. Activation of REV-ERB receptors influences transcriptional regulatory networks through recruitment of corepressor complexes, including NCoR and HDAC3, resulting in suppression of target gene expression. Experimental investigations have examined SR-9011 in studies of circadian clock regulation, transcriptional control mechanisms, nuclear receptor signaling, and coordinated gene regulatory networks. Research applications include REV-ERB pharmacology, circadian rhythm signaling investigation, transcriptional regulation studies, nuclear receptor biology, and mechanistic evaluation of circadian-associated regulatory systems.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

Properties

Chemical Formula C23H31ClN4O3S
Synonyms SR9011, REV-ERBα/β agonist
Molar Mass 479.0 g/mol
CAS Number 1379686-29-9
PubChem CID 57394021
Total Compound Content 300 mg (5 mg per capsule)
Shelf Life 36 months

Research

SR-9011 is a synthetic dual agonist of REV-ERBα (NR1D1) and REV-ERBβ (NR1D2), nuclear receptors that function as transcriptional repressors within circadian and metabolic regulatory networks. Activation of REV-ERB receptors promotes recruitment of corepressor complexes, including NCoR and HDAC3, resulting in suppression of target gene transcription and modulation of downstream regulatory pathways. Experimental investigations have examined SR-9011 in studies of circadian clock signaling, transcriptional control mechanisms, nuclear receptor pharmacology, and coordinated gene regulatory networks. Its activity at both REV-ERB receptor subtypes makes it a valuable research tool for investigating transcriptional repression, receptor-cofactor interactions, circadian-associated signaling pathways, and mechanistic aspects of REV-ERB-mediated gene regulation. Supplied in 5 mg capsules. Independently third-party HPLC-tested; COA available per batch.

FAQ

How does SR-9011 affect REV-ERB-mediated transcriptional regulation?

SR-9011 is a dual agonist of REV-ERBα and REV-ERBβ, nuclear receptors that function as transcriptional repressors within gene regulatory networks. Activation of REV-ERB receptors promotes recruitment of corepressor complexes to response elements within target genes, resulting in suppression of transcriptional activity.

This mechanism makes SR-9011 a valuable research tool for investigating transcriptional repression, receptor-cofactor interactions, and nuclear receptor-mediated gene regulation.

What makes SR-9011 useful for REV-ERB pharmacology research?

SR-9011 activates both REV-ERBα and REV-ERBβ, providing a single molecular tool for studying coordinated REV-ERB receptor signaling. Experimental investigations have utilized SR-9011 to examine receptor activation mechanisms, transcriptional control processes, circadian-associated regulatory pathways, and interactions between nuclear receptors and corepressor complexes.

Its dual-receptor profile makes it particularly useful for comparative studies of REV-ERB-mediated signaling systems.

What are the primary research applications of SR-9011?

SR-9011 is widely used in studies of REV-ERB pharmacology, circadian-associated signaling networks, transcriptional regulation, and nuclear receptor biology. Research applications include investigation of receptor-mediated gene repression, response element regulation, cofactor recruitment mechanisms, and coordinated regulatory pathways controlled by REV-ERB receptors.

These characteristics make SR-9011 a valuable tool for mechanistic studies of transcriptional control and nuclear receptor signaling systems.

Capsule excipients are not specified in the available product documentation.